Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

42 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma.
Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Hendrix MJ, et al. Among authors: hess ar. Nat Rev Cancer. 2003 Jun;3(6):411-21. doi: 10.1038/nrc1092. Nat Rev Cancer. 2003. PMID: 12778131 Review.
Lysyl oxidase regulates breast cancer cell migration and adhesion through a hydrogen peroxide-mediated mechanism.
Payne SL, Fogelgren B, Hess AR, Seftor EA, Wiley EL, Fong SF, Csiszar K, Hendrix MJ, Kirschmann DA. Payne SL, et al. Among authors: hess ar. Cancer Res. 2005 Dec 15;65(24):11429-36. doi: 10.1158/0008-5472.CAN-05-1274. Cancer Res. 2005. PMID: 16357151
VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: implications for vasculogenic mimicry.
Hess AR, Seftor EA, Gruman LM, Kinch MS, Seftor RE, Hendrix MJ. Hess AR, et al. Cancer Biol Ther. 2006 Feb;5(2):228-33. doi: 10.4161/cbt.5.2.2510. Epub 2006 Feb 14. Cancer Biol Ther. 2006. PMID: 16481735
Molecular plasticity of human melanoma cells.
Hendrix MJ, Seftor EA, Hess AR, Seftor RE. Hendrix MJ, et al. Among authors: hess ar. Oncogene. 2003 May 19;22(20):3070-5. doi: 10.1038/sj.onc.1206447. Oncogene. 2003. PMID: 12789282 Review.
Tumor cell vasculogenic mimicry: from controversy to therapeutic promise.
Seftor RE, Hess AR, Seftor EA, Kirschmann DA, Hardy KM, Margaryan NV, Hendrix MJ. Seftor RE, et al. Among authors: hess ar. Am J Pathol. 2012 Oct;181(4):1115-25. doi: 10.1016/j.ajpath.2012.07.013. Epub 2012 Aug 31. Am J Pathol. 2012. PMID: 22944600 Free PMC article. Review.
Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: role of the Eph receptors.
Hess AR, Margaryan NV, Seftor EA, Hendrix MJ. Hess AR, et al. Dev Dyn. 2007 Dec;236(12):3283-96. doi: 10.1002/dvdy.21190. Dev Dyn. 2007. PMID: 17557303 Review.
Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness.
Topczewska JM, Postovit LM, Margaryan NV, Sam A, Hess AR, Wheaton WW, Nickoloff BJ, Topczewski J, Hendrix MJ. Topczewska JM, et al. Among authors: hess ar. Nat Med. 2006 Aug;12(8):925-32. doi: 10.1038/nm1448. Epub 2006 Jul 30. Nat Med. 2006. PMID: 16892036
Focal adhesion kinase promotes the aggressive melanoma phenotype.
Hess AR, Postovit LM, Margaryan NV, Seftor EA, Schneider GB, Seftor RE, Nickoloff BJ, Hendrix MJ. Hess AR, et al. Cancer Res. 2005 Nov 1;65(21):9851-60. doi: 10.1158/0008-5472.CAN-05-2172. Cancer Res. 2005. PMID: 16267008
Effects of angiogenesis inhibitors on vascular network formation by human endothelial and melanoma cells.
van der Schaft DW, Seftor RE, Seftor EA, Hess AR, Gruman LM, Kirschmann DA, Yokoyama Y, Griffioen AW, Hendrix MJ. van der Schaft DW, et al. Among authors: hess ar. J Natl Cancer Inst. 2004 Oct 6;96(19):1473-7. doi: 10.1093/jnci/djh267. J Natl Cancer Inst. 2004. PMID: 15467037
Phosphoinositide 3-kinase regulates membrane Type 1-matrix metalloproteinase (MMP) and MMP-2 activity during melanoma cell vasculogenic mimicry.
Hess AR, Seftor EA, Seftor RE, Hendrix MJ. Hess AR, et al. Cancer Res. 2003 Aug 15;63(16):4757-62. Cancer Res. 2003. PMID: 12941789
42 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback